YTHDF2 and neoplasm: Treatment with oe-KDM5A and oe-MOB3B, however, resulted in decreased tumor size and weight (p < 0.05), increased MOB3B mRNA and protein expression and m6A modification level of MOB3B mRNA (p < 0.05) while no statistical changes were observed in miR-495 expression, mRNA and protein expression of KDM5A and YTHDF2 (p > 0.05).